The purpose of this workshop is to provide NP’s an update on the treatment of patients with HIV. It will include an overview of the issues that have impacted the uptake and use of PrEP, PEP, the newest mediations available for treatment, and a brief discussion on the impact of the end the epidemic initiatives. |1.50 CE/CME category 1 credits (1.50 Pharmacology) | $40

Since electronic nicotine delivery systems or ENDs (e-cigarettes), came to the US market in 2006, their use has increased exponentially, especially in the adolescents along with a proliferation and evolution of devices. Use of ENDs in adolescents has exposed them to nicotine containing tobacco products and well as other substances. There has been some evidence that e-Cigarettes may have some efficacy as a harm reduction tool in certain long term combustible tobacco users, the identification of serious known and potential harms are increasing. We will discuss the evolution of these products, current trends in use, known and potential harms, their potential as harm reduction tool, and their overall impact on public health, and changes in health policies. | 1.0 CE/CME category 1 credits (1.00 Pharmacology) | $30

Preventing unintended pregnancy by providing the most effective contraceptive methods without barriers is more important then ever. Long-acting reversible contraception (LARC) is the safest and most effective contraception available. The implant and IUDs also have the highest patient satisfaction and continuation rates, and yet there remain many barriers to patients accessing these contraceptive methods. We will review common barriers and how to avoid them in your practice. We will discuss how to provide patient centered counselling about LARC methods, tools to provide the most up to date evidence-based care, and how to remove operational barriers in your practice. Whether you don’t provide LARC yet and want to hone your counseling skills and are interested in free training opportunities; or you are an experienced provider of LARC and want to update your practice and learn some helpful tips and tricks-There is something for everyone in this presentation. | 1.50 CE/CME category 1 credits (1.50 Pharmacology) | $40

This presentation will focus on the class of anxiolytics known as the benzodiazepines. Over the years, prescribers have had a love/hate relationship with these controlled substances. Upon completion of this presentation, participants will learn the benefits and risks related to the safe prescribing of benzodiazepines for individuals with various symptom presentations. The presentation will address the risks and cautions related to the prescribing of benzodiazepines with various medications, including the opioids and stimulants and in various healthcare settings. Participants also will receive tips to identify the warning signs of benzodiazepine abuse and techniques to safely taper and discontinue these medications to minimize the discomfort of withdrawal. | 1.0 CE/CME category 1 credits (1.0 Pharmacology) | $30

This presentation offers a comprehensive exploration of Opioid Use Disorder (OUD), equipping nurse practitioners and healthcare professionals with essential tools to address this growing crisis. Attendees will gain a deeper understanding of the assessment and diagnosis of OUD using DSM-5-TR criteria, along with strategies for managing opioid intoxication, overdose, and withdrawal. The session will also cover evidence-based treatment options, both pharmacological and non-pharmacological, emphasizing a patient-centered approach. With a focus on practical application and current statistics, this engaging and informative talk will prepare participants to effectively recognize and treat OUD, ultimately improving patient outcomes. | 1.50 CE/CME category 1 credits (1.50 Pharmacology) | $40

To educate health care providers regarding newly released medications and to discuss the side effects, risks, benefits, and indications of each. | 1.50 CE/CME category 1 credits (1.50 Pharmacology) | $45

To provide the healthcare provider with a brief overview of the pathophysiology of osteoarthritis and rheumatoid arthritis and to discuss the various new and older treatment options currently available. | 1.5 CE/CME category 1 credits (1.50 Pharmacology) | $45

*Supported by an educational grant from Novo Nordisk This presentation will provide information about the new 2025 diabetes guidelines updates published by the American Diabetes Association. Updates to diagnosis, monitoring, lifestyle, and long-term concerns will be outlined as well as highlights of new evidence. Emphasis will be placed on medication treatment for T2DM. | 1.50 CE/CME category 1 credits (1.50 Pharmacology) | $40

This presentation will introduce primary care providers to the mechanism of action of immunotherapies, such as immune checkpoint inhibitors and chimeric antigen receptor T-cell therapies and review several common immune-related adverse events. This presentation will also review the treatment of immune-related adverse events and offer best practices for primary care providers that co-manage patients with cancer. | 1.0 CE/CME category 1 credits (1.00 Pharmacology) | $27.50

The off-label use of psychotropics to manage the neuropsychiatric symptoms associated with dementia is historically widespread. This is despite evidence showing limited benefits and high mortality risk. This interactive presentation is designed to explore a root cause analysis of these neuropsychiatric symptoms using an interdisciplinary approach. A review of recently approved antipsychotics for dementia related agitation will be discussed. | 1.5 CE/CME category 1 credits (1.0 Pharmacology) | $35